Physician profile
Maria Gabriela Velazquez Lamela
NPI 1578907614
$9,960.27
in general payments reported to CMS, 2019-2025
15 companies · $7,332 in 2025
The $7,332 reported for 2025 was more than what 91% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $518 · 2020: $130 · 2021: $338 · 2022: $396 · 2023: $291 · 2024: $955 · 2025: $7,332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,175 · Food and Beverage: $2,280 · Education: $123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,175.00 |
| Food and Beverage | $2,279.98 |
| Education | $122.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $6,678.71 | 2022-2025 | Lumigan |
| New World Medical,INC. | $719.96 | 2022-2025 | Kahook Dual Blade, Streamline, Ahmed Glaucoma Valve |
| Allergan, INC. | $558.43 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $331.24 | 2025 | Acthar |
| Bausch & Lomb Americas INC. | $320.24 | 2022-2024 | Xiidra, Vyzulta, Miebo |
| Alcon Puerto Rico INC | $259.09 | 2024-2025 | Clareon, Unity, Hydrus Microstent |
| Alcon Vision LLC | $236.67 | 2025 | Clareon Panoptix Pro, Rocklatan, Rhopressa |
| Rxsight INC | $217.67 | 2024-2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Novartis Pharmaceuticals Corporation | $201.37 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $200.31 | 2019-2021 | |
| Sight Sciences, INC. | $90.95 | 2023-2024 | Omni Surgical System, Sion Surgical Instrument |
| Ani Pharmaceuticals, INC. | $57.95 | 2025 | Purified Cortrophin Gel |
| Janssen Pharmaceuticals, INC | $47.22 | 2021 | |
| Genentech USA, INC. | $27.09 | 2025 | Vabysmo |
| Apellis Pharmaceuticals, INC. | $13.37 | 2023 | Syfovre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maria Velazquez Lamela listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.